223 related articles for article (PubMed ID: 10231418)
1. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
Murono S; Yoshizaki T; Park CS; Furukawa M
Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.
Burgos JS
Med Oncol; 2005; 22(2):113-21. PubMed ID: 15965273
[TBL] [Abstract][Full Text] [Related]
3. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas].
Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T
Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067
[TBL] [Abstract][Full Text] [Related]
4. Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck.
Yang HJ; Cho YJ; Kim HS; Chang MS; Sung MW; Kim WH
Head Neck; 2001 Aug; 23(8):629-36. PubMed ID: 11443745
[TBL] [Abstract][Full Text] [Related]
5. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
7. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction.
Murono S; Yoshizaki T; Tanaka S; Takeshita H; Park CS; Furukawa M
Laryngoscope; 1997 Apr; 107(4):523-6. PubMed ID: 9111384
[TBL] [Abstract][Full Text] [Related]
8. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
9. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma.
Niemhom S; Kitazawa S; Murao S; Kunachak S; Maeda S
Cancer Lett; 2000 Nov; 160(2):199-208. PubMed ID: 11053650
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
13. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
14. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas.
Niedobitek G; Agathanggelou A; Barber P; Smallman LA; Jones EL; Young LS
J Pathol; 1993 Aug; 170(4):457-61. PubMed ID: 8410495
[TBL] [Abstract][Full Text] [Related]
15. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
[TBL] [Abstract][Full Text] [Related]
17. [Bcl-2, p53 expression and Epstein-Barr virus infection in primary nasopharyngeal carcinoma].
Cheng Q; Liu G; Wu Z; Wu Y; Xiao B
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):455-7. PubMed ID: 12541691
[TBL] [Abstract][Full Text] [Related]
18. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins.
Ishii H; Gobé G; Kawakubo Y; Sato Y; Ebihara Y
Histopathology; 2001 Feb; 38(2):111-9. PubMed ID: 11207824
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
Jeon YK; Lee BY; Kim JE; Lee SS; Kim CW
Head Neck; 2004 Jul; 26(7):573-83. PubMed ID: 15229899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
